Nostos Genomics
Nostos Genomics sold to Limbus Medical Technologies (varvis®)
offmann & Partner is pleased to announce that it has advised the shareholders of Nostos Genomics GmbH (“Nostos”) as M&A advisors in the successful acquisition by Limbus Medical Technologies GmbH (“Limbus”). Two leaders in genomic software are coming together – combining Limbus’ clinical-grade workflows with Nostos’ cutting-edge AI technology for variant interpretation.
Limbus Medical Technologies (varvis®)
Hoffmann & Partner
We support and professionally manage the M&A process from the first steps to the successful transaction. In doing our work we are accustomed to outmost discretion and swift execution. We help our clients making company value potentials visible and realizing them in transactions. Life sciences and high-tech transactions: We know how to sell (and acquire) technologies and we specialise in complex international transactions of technology companies. M&A in the regional service and industrial sectors of Switzerland: As the leading M&A firm in the Basel area, we are very experienced with company sales and acquisitions in the regional industries of Northwestern Switzerland and neighbouring economic regions. Many of these transactions are international.
+41 61 485 93 00
ubreitenstein@hoffmann-partner.com
http://hoffmann-partner.com/en/
